Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

While new treatments that target these proteins offer hope, Alzheimer’s disease is complex and requires a variety of ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic ...

Diagnosing Alzheimer's disease before people have any symptoms is possible, but brings up concerns when so few treatments are ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q4 2024 Earnings Call Transcript March 4, 2025 Amylyx Pharmaceuticals, Inc.